Metabolic Profiling and Detoxification of Eupalinolide A and B in Human Liver Microsomal Systems
Toxics · 09.03.2026 · 14 (3) · 235
DOI: 10.3390/toxics14030235 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxics, online erschienen am 09.03.2026. Verfasst von Yingzi Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology, School of Public Health, Peking University, Beijing 100191, China. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province (Joint Foundation for Innovation and Devel-opment).
Abstract (Originalsprache)
Eupalinolide A (EA, Z-configuration) and Eupalinolide B (EB, E-configuration) are cis-trans isomeric sesquiterpenoid monomers isolated from Eupatorium lindleyanum DC. (Asteraceae). Although these compounds display anti-inflammatory and anti-tumor activities, their metabolite profiles and possible hepatotoxicity remain largely unknown. This study aimed to investigate the metabolic profiles of EA and EB in liver microsomes and clarify whether they undergo metabolic activation or detoxification. EA and EB were metabolically profiled in human liver microsomes (HLMs) via UPLC-Q-TOF-MS. A HepG2-HLM co-culture system was used to compare the hepatocyte toxicity of parent compounds and their hydrolysis, oxidation, and hydrolysis–oxidation metabolites, thus evaluating their metabolic detoxification pathways. Sixteen metabolites of EA and 19 of EB were identified, with hydrolysis being the predominant metabolic pathway for both isomers. Both compounds showed low hepatocyte toxicity and underwent metabolic detoxification mainly via hydrolytic and oxidative pathways. Notably, hydrolysis metabolites had significantly lower toxicity than oxidative products in HepG2 cells. These results suggest that EA and EB could present a relatively low risk of in vivo hepatotoxicity, which provides useful information for understanding the metabolic behavior and safety profile of these bioactive sesquiterpenoids.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Toxicology, School of Public Health, Peking University, Beijing 100191, China.
- Key Laboratory of State Administration of Traditional Chinese Medicine for Compatibility Toxicology, School of Public Health, Peking University, Beijing 100191, China.
- Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, School of Public Health, Peking University, Beijing 100191, China.
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
- Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing 100191, China.
ORCID-Profile: Wusheng Xiao, Youbo Zhang, Qi Wang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province (Joint Foundation for Innovation and Devel-opment)
Zitieren
APA
Li, Y., Liu, X., Li, L., Xiao, W., Zhang, Y., Zeng, K., & Wang, Q. (2026). Metabolic Profiling and Detoxification of Eupalinolide A and B in Human Liver Microsomal Systems. Toxics, 14(3), 235. https://doi.org/10.3390/toxics14030235
Vancouver
Li Y, Liu X, Li L, Xiao W, Zhang Y, Zeng K, et al. Metabolic Profiling and Detoxification of Eupalinolide A and B in Human Liver Microsomal Systems. Toxics. 2026;14(3):235. doi:10.3390/toxics14030235
BibTeX
@article{Li2026,
author = {Li, Yingzi and Liu, Xiaoyan and Li, Ludi and Xiao, Wusheng and Zhang, Youbo and Zeng, Kewu and Wang, Qi},
title = {Metabolic Profiling and Detoxification of Eupalinolide A and B in Human Liver Microsomal Systems},
journal = {Toxics},
year = {2026},
volume = {14},
number = {3},
pages = {235},
doi = {10.3390/toxics14030235}
}
EUVIMED